Sue Ma

In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Kai Lin, Yu-Ping Luong et al. · Journal of Biological Chemistry · 2004 · 289 citations · Full text

In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Cynthia A. Gates, B. Govinda Rao et al. · Journal of Biological Chemistry · 2005 · 216 citations · Full text

Viral Hepatitis, Ns3.4a Serine Protease, Natural Sciences +14

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

Sue Ma, Joanna E. Boerner, Choi-Lai Tiong-Yip et al. · Antimicrobial Agents and Chemotherapy · 2006 · 160 citations · Full text

Immunology, Molecular Biology, Various Cyclosporine Derivatives +16

Mechanism of Resistance of Hepatitis C Virus Replicons to Structurally Distinct Cyclophilin Inhibitors

Xiaoling Puyang, Danielle L. Poulin, Joanna E. Mathy et al. · Antimicrobial Agents and Chemotherapy · 2010 · 73 citations · Full text

Immunology, Molecular Biology, Pharmacotherapy +19

Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance

Joanna E. Mathy, Sue Ma, Teresa Compton et al. · Antimicrobial Agents and Chemotherapy · 2008 · 64 citations · Full text

Hcv Replicon, Protease Inhibitor, Medicine +14